Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 3 |
| List of Tables | 3 | 1 |
| List of Figures | 4 | 1 |
| Report Guidance | 5 | 1 |
| Clinical Trials by Region | 6 | 9 |
| Clinical Trials and Average Enrollment by Country | 7 | 3 |
| Top Five Countries Contributing to Clinical Trials in Asia-Pacific | 10 | 1 |
| Top Five Countries Contributing to Clinical Trials in Europe | 11 | 1 |
| Top Countries Contributing to Clinical Trials in North America | 12 | 1 |
| Top Five Countries Contributing to Clinical Trials in Middle East and Africa | 13 | 1 |
| Top Five Countries Contributing to Clinical Trials in Central and South America | 14 | 1 |
| Clinical Trials by G7 Countries: Proportion of Hemophilia A to Hematological Disorders Clinical Trials | 15 | 1 |
| Clinical Trials by Phase in G7 Countries | 16 | 1 |
| Clinical Trials in G7 Countries by Trial Status | 17 | 1 |
| Clinical Trials by E7 Countries: Proportion of Hemophilia A to Hematological Disorders Clinical Trials | 18 | 1 |
| Clinical Trials by Phase in E7 Countries | 19 | 1 |
| Clinical Trials in E7 Countries by Trial Status | 20 | 1 |
| Clinical Trials by Phase | 21 | 2 |
| In Progress Trials by Phase | 22 | 1 |
| Clinical Trials by Trial Status | 23 | 1 |
| Clinical Trials by End Point Status | 24 | 1 |
| Subjects Recruited Over a Period of Time | 25 | 1 |
| Clinical Trials by Sponsor Type | 26 | 1 |
| Prominent Sponsors | 27 | 3 |
| Top Companies Participating in Hemophilia A Therapeutics Clinical Trials | 28 | 2 |
| Prominent Drugs | 30 | 1 |
| Latest Clinical Trials News on Hemophilia A | 31 | 8 |
| Jul 27, 2016: CSL Behring Presents Pivotal Efficacy Data for AFSTYLA In Adolescents and Children with Hemophilia A at the World Federation of Hemophilia 2016 World Congress | 31 | 1 |
| Jul 26, 2016: Sangamo BioSciences Announces New Gene Therapy Clinical Development Program for Treatment Of Hemophilia A | 32 | 1 |
| Jul 26, 2016: ADYNOVATE Phase 3 Efficacy and Safety Data in Children to be Showcased During International Congress of the World Federation of Hemophilia | 32 | 2 |
| Jul 26, 2016: SIPPET Study was WFH 2016 World Congress Highlight | 34 | 1 |
| Jul 25, 2016: Alnylam Announces New Positive Interim Phase 1 Study Results for Fitusiran, a Once-Monthly, Subcutaneous, Investigational RNAi Therapeutic Targeting Antithrombin for the Treatment of Hemophilia and Rare Bleeding Disorders | 34 | 2 |
| Jul 25, 2016: Alnylam to Report New Clinical Results with Fitusiran at the World Federation of Hemophilia 2016 World Congress | 36 | 1 |
| Jul 19, 2016: CSL Behring to Present New Data for AFSTYLA at the World Federation of Hemophilia 2016 World Congress | 36 | 1 |
| Jul 19, 2016: Shire reinforces commitment in Hematology with robust data presented at international congress of the World Federation of Hemophilia | 37 | 1 |
| Jul 18, 2016: Biogen and Sobi to Showcase Long-Term Efficacy and Safety Data on ELOCTATE at World Federation of Hemophilia 2016 World Congress | 37 | 1 |
| Jul 18, 2016: Biogen and Sobi to Showcase Data on FVIIIFc-VWF-XTEN at World Federation of Hemophilia 2016 World Congress | 38 | 1 |
| Clinical Trial Profile Snapshots | 39 | 186 |
| Appendix | 225 | 4 |
| Abbreviations | 225 | 1 |
| Definitions | 225 | 1 |
| Research Methodology | 226 | 1 |
| Secondary Research | 226 | 1 |
| About GlobalData | 227 | 1 |
| Contact Us | 227 | 1 |
| Disclaimer | 227 | 1 |
| Source | 228 | 1 |